Purchase Order 75F40120P00705
Award Date 9/22/20
Potential Completion Date 1/31/24
Potential Value $225K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Berwyn Heights, MD 20740, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration awarded a $116,289 firm fixed-price purchase order to Oxford Nanopore Technologies Inc., a biotechnology company specializing in nanopore-based electronic systems for genomic sequencing. The contract, awarded on September 16, 2021, with an ultimate completion date of August 24, 2027, encompasses GridION software licenses and device warranties, as well as Oltrax software licenses and device warranties. These products address limitations in traditional...
- The Food and Drug Administration awarded a $87,005 firm fixed-price purchase order to Oxford Nanopore Technologies Inc. for one long-read sequencing instrument and one automated library preparation instrument. The contract, designated as a Total Small Business set-aside, was awarded on September 13, 2022, with an ultimate completion date of March 7, 2028. Performance will take place in New York, NY. Oxford Nanopore Technologies is a biotechnology company specializing in nanopore-based sequencing...
- This is a $23,050.00 firm fixed price purchase order awarded to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services. The contract is for the delivery of a PromethION 2 Solo CAPEX Sequencing Unit, a next-generation genomic sequencing platform developed by Oxford Nanopore. This award is not associated with a set-aside program and is the latest in a...
- Oxford Nanopore Technologies Inc. was awarded a $25,000 firm fixed price purchase order by the Department of Health and Human Services Food and Drug Administration to deliver GridION software licenses. The solicitation sought GridION software or equal, including device warranty. As a foreign owned for-profit organization, Oxford Nanopore Technologies Inc. develops nanopore sequencing systems and supplies consumables to support genomic research. They have provided equipment, reagents, kits and...
- Oxford Nanopore Technologies Inc. was awarded a $100,060 firm fixed-price purchase order by the U.S. Department of Health and Human Services Food and Drug Administration (FDA) for a total small business set-aside requirement of two portable long-read whole genome sequencers to support the FDA's epidemiologic investigations and surveillance for foodborne pathogens like Escherichia coli and Clostridium botulinum. The sequencers and associated consumables, support, and installation services are...
- The U.S. Food and Drug Administration awarded a firm fixed-price purchase order valued at $295,137 to Oxford Nanopore Technologies Inc. for the lease of a PromethION 2 Solo long-read sequencing instrument and associated consumables. The award, announced on September 18, 2024, supports the FDA's research initiatives at its Laurel, Maryland facility, specifically addressing the safety assessment of gene editing technologies in food and drug-producing animals and multiple studies conducted by the...
- The National Human Genome Research Institute (NHGRI), a civilian agency, awarded a $23,590.00 firm fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for the supply of 3 packs of 4 PromethION flow cell packs (RNA) with a period of performance through December 31, 2024. This award does not have a set-aside designation. Oxford Nanopore Technologies Inc. has secured numerous prime federal contract awards from agencies such as the National...
- This federal contract award to Oxford Nanopore Technologies Inc., a division of Oxford Nanopore Technologies PLC, is for the procurement of a PromethION high throughput sequencing system. The $134,999.99 firm-fixed price purchase order was awarded by the U.S. Department of Agriculture's Animal and Plant Health Inspection Service Veterinary Services and has a completion date of September 30, 2018. The contract does not have a set-aside designation. Oxford Nanopore Technologies Inc. is an...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health, National Human Genome Research Institute to Oxford Nanopore Technologies Inc. for a PROMETHION 24 system. The contract has a completion date of July 31, 2019 and a potential value of $165,000.00. The contract does not have a set-aside designation. Based on Oxford Nanopore Technologies Inc.'s past federal contract work, they provide next-generation genomic...
- This federal contract award was made by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The $376,365.00 firm fixed-price purchase order is for the delivery of PromethION Instrument Reagents, which support the agency's genomic research and analysis work. The contract has an ultimate completion date of June 30, 2026 and does not utilize any...